Price target
20.800.000.00%
The 10 analysts offering 1 year price forecasts for YMAB have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to YMAB in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
YMAB EPS for the last quarter is −0.21 USD despite the estimation of −0.12 USD. In the next quarter EPS is expected to reach −0.16 USD. Track more of Y-mAbs Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Y-mAbs Therapeutics, Inc. revenue is expected to reach 23.28 M USD. Check out Y-mAbs Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, YMAB price target is 20.80 USD with a max estimate of 26.00 USD and a min estimate of 11.00 USD. Check if this forecast comes true in a year, meanwhile watch Y-mAbs Therapeutics, Inc. stock price chart and keep track of the current situation with YMAB news and stock market news.
We've gathered opinions of 10 analysts rating YMAB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.